Barbara E. Corkey, Ph.D. is Professor of Medicine and Biochemistry at Boston University School of Medicine. Dr. Corkey is the Past-President of NAASO, the Obesity Society, Director of the city-wide NIH-funded Boston Obesity/Nutrition Research Center, and Director of the Obesity Research Center at Boston University School of Medicine. Dr. Corkey is the recipient of an NIH MERIT Award and the Charles H. Best Lectureship and Award from the University of Toronto. She has been a member of the NIH Metabolism Study Section, co-Chair of the Juvenile Diabetes Foundation Scientific Review Board on Hormone Action and Metabolism, an Associate Editor of the journal Diabetes and she currently is Editor-in-Chief of the journal Obesity Research. She has published over 100 peer-reviewed articles and is frequently an invited speaker at national and international institutions and symposia. Dr. Corkey received her Ph.D. from the University of Pennsylvania in biochemistry and biophysics.
Stephen R. Farmer, Ph.D. Dr. Farmer is a Professor in the Department of Biochemistry at Boston University School of Medicine (BUSM). Dr. Farmer has been a member of the faculty at BUSM since 1981 and prior to that was a research associate at the Massachusetts Institute of Technology. During the last 15 years his investigations have focused on the role of transcription factors in regulating expression of metabolic genes during the switch between growth and differentiation in hepatocytes and adipocytes. Dr. Farmer has also served on several review committees for NIH and the American Heart Association and is a member of the editorial board of the Journal of Biological Chemistry and Obesity Research. He also serves on the planning committee for the Annual Meeting of the North American Association for the Study of Obesity (NAASO) and has chaired several meetings including the 2004 Keystone meeting on Molecular Aspects of Adipogenesis and Obesity.
James A. Hamilton, Ph.D. Dr. James A. Hamilton is currently Professor of Biophysics and Research Medicine, Director of the NMR Laboratory at Boston University School of Medicine, and Director of the Cardiovascular Magnetic Resonance Spectroscopy and Imaging. He is internationally known for his novel applications of NMR to study lipid dynamics in lipoproteins, lipid-protein interactions, and the structures within atherosclerotic plaques. His research has provided new insights into fatty acid transport across membranes and into living cells through the development of novel fluorescence approaches. New imaging studies in his lab have detected thrombus associated with plaque rupture in an animal model of atherothrombosis. He is Associate Editor of Lipids, Obesity Research and on the editorial board of the Journal of Lipid Research. Dr. Hamilton has published over 125 peer-reviewed articles, including several articles in Science and in Proceedings of the National Academy of Sciences, USA. He is a founding organizer of the International Workshop, Brain Uptake and Utilization of Fatty Acids, held in Bethesda in 2000 and 2004.
James L. Kirkland, M.D, Ph.D. Dr. Kirkland is an Associate Professor in the Departments of Medicine and Biochemistry at Boston University School of Medicine. He is Director of the Adipocyte Core of the Boston Obesity and Nutrition Research Center. Dr. Kirkland has over 70 publications and 14 years of experience with human and rodent preadipocyte and fat cell systems. His is one of the few laboratories in the world that can produce differentiated cultured human preadipocytes. Additionally, he is a specialist in Internal Medicine, Geriatric Medicine, and Endocrinology and Metabolism and is a Fellow o the American College of Physicians.
H. Jeff Leighton, Ph.D. Dr. Leighton has over 20 years of successful discovery, development and business experience in the biotechnology and pharmaceutical industries. In 1997 Dr. Leighton founded BioDesign, Inc., a strategic planning company for research and development where he is CEO. He is a Founder and the Chairman of ICAgen, a late stage pre-IPO company and is a Founder and the Director of Inspire Pharmaceuticals (IPO August 2000). Dr. Leighton was Executive Vice President of Research and Development at Sphinx Pharmaceuticals and Vice President of Research at GlaxoWellcome from 1986 to 1991. Dr. Leighton received his B.S. and M.S. in chemistry from the University of South Carolina and his Ph.D. in pharmacology from the University of Virginia.
Paul F. Pilch, Ph.D. Dr. Pilch is Professor of Biochemistry and Research Professor of Biophysics at Boston University School of Medicine kamagra 100. He has served on NIH and NSF study sections and on the program planning committee for the Annual meeting of the American Diabetes Association, which he chaired He has published over 100 peer-reviewed articles and reviews focusing primarily on insulin receptor signaling and the regulation of vesicular traffic involving glucose transporters. Dr. Pilch is currently serving on the Editorial Board of Physiological Reviews, and he is an Editor of Molecular Endocrinology and Obesity Research. Dr. Pilch's research interests include the compartmentalization of signal transduction pathways and regulated vesicular trafficking in adipocytes and muscle.